Lannett Company Inc. recalls Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, Ph…
- Recall date
- February 21, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0996-2019
- FDA classification
- Class III
- Brand / firm
- Lannett Company Inc.
- Sold / distributed
- Nationwide, including Puerto Rico.
Why it was recalled
Failed Dissolution Specifications
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, Philadelphia, PA 19154 NDC: 62175-271-37
Get recall alerts
Free email alert whenever Lannett Company Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Lannett Company Inc.